Three IPOs debuted this past week. Three IPOs and one SPAC submitted initial filings this week. Product assessment services provider UL Solutions (ULS) priced its upsized IPO above the midpoint to raise $946 million at a $5.7 billion market...read more
Mobile-health Network Solutions, which provides a platform for telehealth and other healthcare services in the APAC region, raised $9 million by offering 2.3 million shares at $4, the low end of the range of $4 to $5. The company provides services through its...read more
Updated Monday, 4/1. The April IPO market is starting off with a fairly quiet calendar, with one large issuer scheduled for the week ahead. That could change, as several issuers are teed up for potential launches. Potential calendar additions include...read more
Three listings are currently scheduled for the week ahead, although other issuers may join the calendar throughout the week. Phase 1 oncology biotech Boundless Bio (BOLD) plans to raise $100 million at a $396 million market cap. The company...read more
US IPO Weekly Recap: 3 IPOs raise over $1.4 billion, led by UL Solutions
Three IPOs debuted this past week. Three IPOs and one SPAC submitted initial filings this week. Product assessment services provider UL Solutions (ULS) priced its upsized IPO above the midpoint to raise $946 million at a $5.7 billion market...read more
Singapore-based telehealth company Mobile-health Network Solutions prices US IPO at $4 low end
Mobile-health Network Solutions, which provides a platform for telehealth and other healthcare services in the APAC region, raised $9 million by offering 2.3 million shares at $4, the low end of the range of $4 to $5. The company provides services through its...read more
US IPO Week Ahead: IPO market starts with a quiet week as potential launches loom
Updated Monday, 4/1. The April IPO market is starting off with a fairly quiet calendar, with one large issuer scheduled for the week ahead. That could change, as several issuers are teed up for potential launches. Potential calendar additions include...read more
US IPO Week Ahead: Oncology biotech leads 3 IPO week
Three listings are currently scheduled for the week ahead, although other issuers may join the calendar throughout the week. Phase 1 oncology biotech Boundless Bio (BOLD) plans to raise $100 million at a $396 million market cap. The company...read more